Metastatic Melanoma News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Gene associated with metastatic melanoma identified - Science Daily



Gene associated with metastatic melanoma identified 
Science Daily
A study by Craig J. Ceol, PhD, assistant professor of molecular medicine at the University of Massachusetts Medical School, has revealed a protein active during early embryo development called GDF6 plays a primary role in metastatic melanoma. Published ...

and more » 


Metastatic Melanoma - News-Medical.net



News-Medical.net
 
Metastatic Melanoma 
News-Medical.net
Melanoma is a type of skin cancer. When melanoma spreads to other parts of the body, it's called metastatic melanoma, or stage IV melanoma. Some common sites for metastatic melanoma are the liver, lungs, bones, and brain. Melanoma is a cancer of ...

 


Study reveals gene linked to metastatic melanoma - News-Medical.net



News-Medical.net
 
Study reveals gene linked to metastatic melanoma 
News-Medical.net
A study by Craig J. Ceol, PhD, assistant professor of molecular medicine at the University of Massachusetts Medical School, has revealed a protein active during early embryo development called GDF6 plays a primary role in metastatic melanoma. Published ...

and more » 


Scientists identify novel therapeutic targets for metastatic melanoma - Science Daily



Scientists identify novel therapeutic targets for metastatic melanoma 
Science Daily
"Melanoma is the most aggressive form of skin cancer, affecting more and more patients," according to the study's senior author, Emily Bernstein, PhD, Associate Professor of Oncological Sciences and Dermatology at The Tisch Cancer Institute at the ...

and more » 


Reata Pharmaceuticals, Inc. Presents Interim Phase 1b Data for Omaveloxolone in the Treatment of Unresectable or ... - GlobeNewswire (press release)



Reata Pharmaceuticals, Inc. Presents Interim Phase 1b Data for Omaveloxolone in the Treatment of Unresectable or ... 
GlobeNewswire (press release)
IRVING, Texas, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (?Reata? or ?the Company?), a clinical-stage biopharmaceutical company, today announced the presentation of interim data from the ongoing Phase 1b portion of the ...
Reata Pharma (RETA) Reports Interim Phase 1b Data for Omaveloxolone in the Treatment of Unresectable or ... StreetInsider.com

all 1 news articles » 


UMMS scientists identify gene associated with metastatic melanoma - EurekAlert (press release)



UMMS scientists identify gene associated with metastatic melanoma 
EurekAlert (press release)
WORCESTER, MA - A study by Craig J. Ceol, PhD, assistant professor of molecular medicine at the University of Massachusetts Medical School, has revealed a protein active during early embryo development called GDF6 plays a primary role in metastatic ...

and more » 


The Challenges of Immunotherapy Re-challenge in Metastatic Melanoma - Cancer Therapy Advisor



Cancer Therapy Advisor
 
The Challenges of Immunotherapy Re-challenge in Metastatic Melanoma 
Cancer Therapy Advisor
It is not always clear whether patients who discontinue anti-PD-1 and -CTLA-4 therapy should re-initiate treatment after adverse events are resolved. Immune checkpoint inhibitors targeting CLTA-4 and PD-1 are dramatically improving survival rates among ...

 


Immunocore's IMCgp100 Receives Promising Innovative Medicine (PIM) Designation Under UK Early Access to ... - Markets Insider



Immunocore's IMCgp100 Receives Promising Innovative Medicine (PIM) Designation Under UK Early Access to ... 
Markets Insider
(Oxford, UK and Conshohocken, US, 11 December 2017) Immunocore Limited, the world's leading TCR company focused on delivering first-in-class biological therapies that transform lives, today announces that it has been informed by the UK's Medicines and ...
Immunocore's IMCgp100 Receives Promising Innovative Medicine ... GlobeNewswire (press release)

all 1 news articles » 


Metastatic Melanoma Treatment Granted Fast Track Designation - Pharmaceutical Processing



Immuno-Oncology News
 
Metastatic Melanoma Treatment Granted Fast Track Designation 
Pharmaceutical Processing
U.S. FDA grants Fast Track designation for Idera Pharmaceuticals' IMO-2125 in combination with ipilimumab for treatment of PD-1 refractory metastatic melanoma. The Food and Drug Administration (FDA) has placed Idera Pharmaceutical's lead development ...
IMO-2125, Yervoy Combo is on Fast Track for Treating Refractory Metastatic Melanoma Immuno-Oncology News

all 2 news articles » 


Novel Compound Restores Immune Response in Patients with Melanoma - Drug Discovery & Development



Drug Discovery & Development
 
Novel Compound Restores Immune Response in Patients with Melanoma 
Drug Discovery & Development
A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017. (1). "Checkpoint inhibitors are a standard of care immunotherapy for metastatic melanoma," said lead ...

and more »